RT @ANZDATARegistry: The open access qualitative protocol paper for SWIFT (one of our registry-based trials) is now available. https://t.c…
RT @ANZDATARegistry: The open access qualitative protocol paper for SWIFT (one of our registry-based trials) is now available. https://t.c…
RT @ANZDATARegistry: The open access qualitative protocol paper for SWIFT (one of our registry-based trials) is now available. https://t.c…
The open access qualitative protocol paper for SWIFT (one of our registry-based trials) is now available. https://t.co/TEovuEuXqS
RT @TrialsCentre: >3 million people worldwide receive treatment for #KidneyDisease. #Haemodialysis can cause a high symptom burden and impa…
RT @TrialsCentre: >3 million people worldwide receive treatment for #KidneyDisease. #Haemodialysis can cause a high symptom burden and impa…
RT @TrialsCentre: >3 million people worldwide receive treatment for #KidneyDisease. #Haemodialysis can cause a high symptom burden and impa…
Pleased to have 3 of our @CentralAdlLHN @SAHealth dialysis sites as pilot sites for the @SWIFTrial #PROMS in #dialysis @ANZDATARegistry
RT @TrialsCentre: >3 million people worldwide receive treatment for #KidneyDisease. #Haemodialysis can cause a high symptom burden and impa…
RT @TrialsCentre: >3 million people worldwide receive treatment for #KidneyDisease. #Haemodialysis can cause a high symptom burden and impa…
>3 million people worldwide receive treatment for #KidneyDisease. #Haemodialysis can cause a high symptom burden and impaired quality of life. Study from co-author our @RachaelMorton12 looks at feasibility of electronic patient-reported outcome measures